A statement released earlier today by Goldman Sachs Group Inc. about Cardinal Health Inc (NYSE:CAH) bumps down the target price to $83.00
- Updated: September 15, 2016
Only yesterday Cardinal Health Inc (NYSE:CAH) traded 0.91% lower at $76.60. CAH’s 50-day average is $81.46 and its 200-day moving average is $80.81. With the last stock price close down 6.07% relative to the two hundred day average, compared to the Standard & Poor’s 500 Index which has fallen -0.01% over the date range. Volume of trade was was down over the average, with 716,266 shares of CAH changing hands under the typical 2,134,280 shares..
Cardinal Health Inc (NYSE:CAH) had its price target lowered to $83 by Goldman Sachs Group Inc. in a report released 9/16/2016. The latest target price indicates a potential upside of 0.08% from the bussiness’ last closing price.
Previously on 8/04/2016, Deutsche Bank reported on Cardinal Health Inc(NYSE:CAH) bumped the target price from $83.00 to $89.00 that indicated a possible upside of 0.06%.
A total of 15 analysts have released a report on the stock. Seven analysts rate the stock a strong buy, five analysts rate the company a buy, seven firms rate the company a hold, 0 rate the stock to underperform, and finally 0 firmsrate the stock as sell with a 12-month target of $91.93
With a total market value of $0.0, Cardinal Health Inc has a one-year low of $73.25 and a 52 week high of $91.23 with a PE ratio of 18.
Brief Synopsis On Cardinal Health Inc (NYSE:CAH)
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and and software to hospitals.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.